EP3383524A1 - Mélange de polymères sulfonés zwitterioniques et membrane à fibres creuses - Google Patents
Mélange de polymères sulfonés zwitterioniques et membrane à fibres creusesInfo
- Publication number
- EP3383524A1 EP3383524A1 EP16871564.7A EP16871564A EP3383524A1 EP 3383524 A1 EP3383524 A1 EP 3383524A1 EP 16871564 A EP16871564 A EP 16871564A EP 3383524 A1 EP3383524 A1 EP 3383524A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- polymer
- formula
- hollow
- independently
- structural units
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 154
- 150000003457 sulfones Chemical class 0.000 title claims abstract description 120
- 239000012510 hollow fiber Substances 0.000 title claims abstract description 94
- 229920002959 polymer blend Polymers 0.000 title abstract description 19
- 229920000642 polymer Polymers 0.000 claims abstract description 257
- 239000000203 mixture Substances 0.000 claims abstract description 35
- 125000003118 aryl group Chemical group 0.000 claims description 60
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 claims description 38
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 38
- 238000005266 casting Methods 0.000 claims description 34
- 238000000034 method Methods 0.000 claims description 28
- 125000005843 halogen group Chemical group 0.000 claims description 22
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 22
- 230000008569 process Effects 0.000 claims description 18
- 238000001631 haemodialysis Methods 0.000 claims description 11
- 230000000322 hemodialysis Effects 0.000 claims description 11
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 claims description 10
- 239000001257 hydrogen Substances 0.000 claims description 10
- 229910052739 hydrogen Inorganic materials 0.000 claims description 10
- 229920002492 poly(sulfone) Polymers 0.000 claims description 10
- 238000002615 hemofiltration Methods 0.000 claims description 8
- 229920006393 polyether sulfone Polymers 0.000 claims description 4
- 229920000491 Polyphenylsulfone Polymers 0.000 claims description 3
- 239000004695 Polyether sulfone Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 29
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 16
- 238000006243 chemical reaction Methods 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 150000001875 compounds Chemical class 0.000 description 13
- -1 2- methylcyclopentyl Chemical group 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 108090000623 proteins and genes Proteins 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 239000002904 solvent Substances 0.000 description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 238000000926 separation method Methods 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 239000011521 glass Substances 0.000 description 6
- 238000001471 micro-filtration Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000000654 additive Substances 0.000 description 5
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 125000000524 functional group Chemical group 0.000 description 5
- 238000005191 phase separation Methods 0.000 description 5
- 229920001223 polyethylene glycol Chemical group 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 4
- NXXYKOUNUYWIHA-UHFFFAOYSA-N 2,6-Dimethylphenol Chemical compound CC1=CC=CC(C)=C1O NXXYKOUNUYWIHA-UHFFFAOYSA-N 0.000 description 4
- 239000002202 Polyethylene glycol Chemical group 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- 239000004305 biphenyl Substances 0.000 description 4
- PXKLMJQFEQBVLD-UHFFFAOYSA-N bisphenol F Chemical compound C1=CC(O)=CC=C1CC1=CC=C(O)C=C1 PXKLMJQFEQBVLD-UHFFFAOYSA-N 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 239000010408 film Substances 0.000 description 4
- 238000007306 functionalization reaction Methods 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 150000003462 sulfoxides Chemical class 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 229930185605 Bisphenol Natural products 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 3
- HRNLUBSXIHFDHP-UHFFFAOYSA-N N-(2-aminophenyl)-4-[[[4-(3-pyridinyl)-2-pyrimidinyl]amino]methyl]benzamide Chemical compound NC1=CC=CC=C1NC(=O)C(C=C1)=CC=C1CNC1=NC=CC(C=2C=NC=CC=2)=N1 HRNLUBSXIHFDHP-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000005227 gel permeation chromatography Methods 0.000 description 3
- 229920001477 hydrophilic polymer Polymers 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 229920001451 polypropylene glycol Polymers 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 238000002145 thermally induced phase separation Methods 0.000 description 3
- 238000000108 ultra-filtration Methods 0.000 description 3
- HCNHNBLSNVSJTJ-UHFFFAOYSA-N 1,1-Bis(4-hydroxyphenyl)ethane Chemical compound C=1C=C(O)C=CC=1C(C)C1=CC=C(O)C=C1 HCNHNBLSNVSJTJ-UHFFFAOYSA-N 0.000 description 2
- OWEYKIWAZBBXJK-UHFFFAOYSA-N 1,1-Dichloro-2,2-bis(4-hydroxyphenyl)ethylene Chemical group C1=CC(O)=CC=C1C(=C(Cl)Cl)C1=CC=C(O)C=C1 OWEYKIWAZBBXJK-UHFFFAOYSA-N 0.000 description 2
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Chemical compound C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 2
- XKZQKPRCPNGNFR-UHFFFAOYSA-N 2-(3-hydroxyphenyl)phenol Chemical compound OC1=CC=CC(C=2C(=CC=CC=2)O)=C1 XKZQKPRCPNGNFR-UHFFFAOYSA-N 0.000 description 2
- LAQYHRQFABOIFD-UHFFFAOYSA-N 2-methoxyhydroquinone Chemical compound COC1=CC(O)=CC=C1O LAQYHRQFABOIFD-UHFFFAOYSA-N 0.000 description 2
- VWGKEVWFBOUAND-UHFFFAOYSA-N 4,4'-thiodiphenol Chemical compound C1=CC(O)=CC=C1SC1=CC=C(O)C=C1 VWGKEVWFBOUAND-UHFFFAOYSA-N 0.000 description 2
- NZGQHKSLKRFZFL-UHFFFAOYSA-N 4-(4-hydroxyphenoxy)phenol Chemical compound C1=CC(O)=CC=C1OC1=CC=C(O)C=C1 NZGQHKSLKRFZFL-UHFFFAOYSA-N 0.000 description 2
- PVFQHGDIOXNKIC-UHFFFAOYSA-N 4-[2-[3-[2-(4-hydroxyphenyl)propan-2-yl]phenyl]propan-2-yl]phenol Chemical compound C=1C=CC(C(C)(C)C=2C=CC(O)=CC=2)=CC=1C(C)(C)C1=CC=C(O)C=C1 PVFQHGDIOXNKIC-UHFFFAOYSA-N 0.000 description 2
- VOWWYDCFAISREI-UHFFFAOYSA-N Bisphenol AP Chemical compound C=1C=C(O)C=CC=1C(C=1C=CC(O)=CC=1)(C)C1=CC=CC=C1 VOWWYDCFAISREI-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 2
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 150000001339 alkali metal compounds Chemical class 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 150000001491 aromatic compounds Chemical class 0.000 description 2
- IMHDGJOMLMDPJN-UHFFFAOYSA-N biphenyl-2,2'-diol Chemical compound OC1=CC=CC=C1C1=CC=CC=C1O IMHDGJOMLMDPJN-UHFFFAOYSA-N 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- NNBZCPXTIHJBJL-UHFFFAOYSA-N decalin Chemical compound C1CCCC2CCCCC21 NNBZCPXTIHJBJL-UHFFFAOYSA-N 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 2
- KZTYYGOKRVBIMI-UHFFFAOYSA-N diphenyl sulfone Chemical compound C=1C=CC=CC=1S(=O)(=O)C1=CC=CC=C1 KZTYYGOKRVBIMI-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000009477 glass transition Effects 0.000 description 2
- 229920006158 high molecular weight polymer Polymers 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000001728 nano-filtration Methods 0.000 description 2
- 238000005373 pervaporation Methods 0.000 description 2
- 239000003880 polar aprotic solvent Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 235000011181 potassium carbonates Nutrition 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 238000001223 reverse osmosis Methods 0.000 description 2
- CPRMKOQKXYSDML-UHFFFAOYSA-M rubidium hydroxide Chemical compound [OH-].[Rb+] CPRMKOQKXYSDML-UHFFFAOYSA-M 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- DEQUKPCANKRTPZ-UHFFFAOYSA-N (2,3-dihydroxyphenyl)-phenylmethanone Chemical compound OC1=CC=CC(C(=O)C=2C=CC=CC=2)=C1O DEQUKPCANKRTPZ-UHFFFAOYSA-N 0.000 description 1
- SICLLPHPVFCNTJ-UHFFFAOYSA-N 1,1,1',1'-tetramethyl-3,3'-spirobi[2h-indene]-5,5'-diol Chemical compound C12=CC(O)=CC=C2C(C)(C)CC11C2=CC(O)=CC=C2C(C)(C)C1 SICLLPHPVFCNTJ-UHFFFAOYSA-N 0.000 description 1
- BSJWDQYZFBYNIM-UHFFFAOYSA-N 1,3,4,5-tetramethylpyrrolidin-2-one Chemical compound CC1C(C)N(C)C(=O)C1C BSJWDQYZFBYNIM-UHFFFAOYSA-N 0.000 description 1
- CYSGHNMQYZDMIA-UHFFFAOYSA-N 1,3-Dimethyl-2-imidazolidinon Chemical compound CN1CCN(C)C1=O CYSGHNMQYZDMIA-UHFFFAOYSA-N 0.000 description 1
- FSSPGSAQUIYDCN-UHFFFAOYSA-N 1,3-Propane sultone Chemical compound O=S1(=O)CCCO1 FSSPGSAQUIYDCN-UHFFFAOYSA-N 0.000 description 1
- BCNBMSZKALBQEF-UHFFFAOYSA-N 1,3-dimethylpyrrolidin-2-one Chemical compound CC1CCN(C)C1=O BCNBMSZKALBQEF-UHFFFAOYSA-N 0.000 description 1
- NCNWTBAWLAFYDR-UHFFFAOYSA-N 1,6-dimethylpiperidin-2-one Chemical compound CC1CCCC(=O)N1C NCNWTBAWLAFYDR-UHFFFAOYSA-N 0.000 description 1
- IVUYGANTXQVDDG-UHFFFAOYSA-N 1-(2-methylpropyl)pyrrolidin-2-one Chemical compound CC(C)CN1CCCC1=O IVUYGANTXQVDDG-UHFFFAOYSA-N 0.000 description 1
- ZFPGARUNNKGOBB-UHFFFAOYSA-N 1-Ethyl-2-pyrrolidinone Chemical compound CCN1CCCC1=O ZFPGARUNNKGOBB-UHFFFAOYSA-N 0.000 description 1
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
- FEWLNYSYJNLUOO-UHFFFAOYSA-N 1-Piperidinecarboxaldehyde Chemical compound O=CN1CCCCC1 FEWLNYSYJNLUOO-UHFFFAOYSA-N 0.000 description 1
- BNXZHVUCNYMNOS-UHFFFAOYSA-N 1-butylpyrrolidin-2-one Chemical compound CCCCN1CCCC1=O BNXZHVUCNYMNOS-UHFFFAOYSA-N 0.000 description 1
- IVVVGBHWWAJRAY-UHFFFAOYSA-N 1-ethyl-3-methylpyrrolidin-2-one Chemical compound CCN1CCC(C)C1=O IVVVGBHWWAJRAY-UHFFFAOYSA-N 0.000 description 1
- VUQMOERHEHTWPE-UHFFFAOYSA-N 1-ethylpiperidin-2-one Chemical compound CCN1CCCCC1=O VUQMOERHEHTWPE-UHFFFAOYSA-N 0.000 description 1
- GVYKABJIEOOUOX-UHFFFAOYSA-N 1-fluoro-4-(4-fluorophenyl)sulfinylbenzene Chemical compound C1=CC(F)=CC=C1S(=O)C1=CC=C(F)C=C1 GVYKABJIEOOUOX-UHFFFAOYSA-N 0.000 description 1
- 125000006432 1-methyl cyclopropyl group Chemical group [H]C([H])([H])C1(*)C([H])([H])C1([H])[H] 0.000 description 1
- GGYVTHJIUNGKFZ-UHFFFAOYSA-N 1-methylpiperidin-2-one Chemical compound CN1CCCCC1=O GGYVTHJIUNGKFZ-UHFFFAOYSA-N 0.000 description 1
- GVDQKJQFVPXADH-UHFFFAOYSA-N 1-propan-2-ylpiperidin-2-one Chemical compound CC(C)N1CCCCC1=O GVDQKJQFVPXADH-UHFFFAOYSA-N 0.000 description 1
- GHELJWBGTIKZQW-UHFFFAOYSA-N 1-propan-2-ylpyrrolidin-2-one Chemical compound CC(C)N1CCCC1=O GHELJWBGTIKZQW-UHFFFAOYSA-N 0.000 description 1
- DCALJVULAGICIX-UHFFFAOYSA-N 1-propylpyrrolidin-2-one Chemical compound CCCN1CCCC1=O DCALJVULAGICIX-UHFFFAOYSA-N 0.000 description 1
- APGLXTXFTYAQKC-UHFFFAOYSA-N 2,5-dihydroxybenzonitrile Chemical compound OC1=CC=C(O)C(C#N)=C1 APGLXTXFTYAQKC-UHFFFAOYSA-N 0.000 description 1
- AYKMXKNVEUMLFQ-UHFFFAOYSA-N 2-(1,8-naphthyridin-2-yl)phenol Chemical compound OC1=CC=CC=C1C1=CC=C(C=CC=N2)C2=N1 AYKMXKNVEUMLFQ-UHFFFAOYSA-N 0.000 description 1
- BLDLRWQLBOJPEB-UHFFFAOYSA-N 2-(2-hydroxyphenyl)sulfanylphenol Chemical compound OC1=CC=CC=C1SC1=CC=CC=C1O BLDLRWQLBOJPEB-UHFFFAOYSA-N 0.000 description 1
- WFNXYMSIAASORV-UHFFFAOYSA-N 2-[1-(2-hydroxyphenyl)cyclohexyl]phenol Chemical compound OC1=CC=CC=C1C1(C=2C(=CC=CC=2)O)CCCCC1 WFNXYMSIAASORV-UHFFFAOYSA-N 0.000 description 1
- WREVCRYZAWNLRZ-UHFFFAOYSA-N 2-allyl-6-methyl-phenol Chemical compound CC1=CC=CC(CC=C)=C1O WREVCRYZAWNLRZ-UHFFFAOYSA-N 0.000 description 1
- MFGOFGRYDNHJTA-UHFFFAOYSA-N 2-amino-1-(2-fluorophenyl)ethanol Chemical compound NCC(O)C1=CC=CC=C1F MFGOFGRYDNHJTA-UHFFFAOYSA-N 0.000 description 1
- GHCZTIFQWKKGSB-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;phosphoric acid Chemical compound OP(O)(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O GHCZTIFQWKKGSB-UHFFFAOYSA-N 0.000 description 1
- YMTYZTXUZLQUSF-UHFFFAOYSA-N 3,3'-Dimethylbisphenol A Chemical compound C1=C(O)C(C)=CC(C(C)(C)C=2C=C(C)C(O)=CC=2)=C1 YMTYZTXUZLQUSF-UHFFFAOYSA-N 0.000 description 1
- RKSBPFMNOJWYSB-UHFFFAOYSA-N 3,3-Bis(4-hydroxyphenyl)pentane Chemical compound C=1C=C(O)C=CC=1C(CC)(CC)C1=CC=C(O)C=C1 RKSBPFMNOJWYSB-UHFFFAOYSA-N 0.000 description 1
- ABHOEQJNEOMTEK-UHFFFAOYSA-N 3,5-dihydroxybenzonitrile Chemical compound OC1=CC(O)=CC(C#N)=C1 ABHOEQJNEOMTEK-UHFFFAOYSA-N 0.000 description 1
- DRYYJQYUHPRVBN-UHFFFAOYSA-N 3-ethyl-1-methylpiperidin-2-one Chemical compound CCC1CCCN(C)C1=O DRYYJQYUHPRVBN-UHFFFAOYSA-N 0.000 description 1
- RXNYJUSEXLAVNQ-UHFFFAOYSA-N 4,4'-Dihydroxybenzophenone Chemical compound C1=CC(O)=CC=C1C(=O)C1=CC=C(O)C=C1 RXNYJUSEXLAVNQ-UHFFFAOYSA-N 0.000 description 1
- GPAPPPVRLPGFEQ-UHFFFAOYSA-N 4,4'-dichlorodiphenyl sulfone Chemical compound C1=CC(Cl)=CC=C1S(=O)(=O)C1=CC=C(Cl)C=C1 GPAPPPVRLPGFEQ-UHFFFAOYSA-N 0.000 description 1
- VPWNQTHUCYMVMZ-UHFFFAOYSA-N 4,4'-sulfonyldiphenol Chemical compound C1=CC(O)=CC=C1S(=O)(=O)C1=CC=C(O)C=C1 VPWNQTHUCYMVMZ-UHFFFAOYSA-N 0.000 description 1
- HSTXWFCGRUJCET-UHFFFAOYSA-N 4,4-bis(4-hydroxyphenyl)-2-phenyl-3ah-isoindole-1,3-dione Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C(C(=O)N(C2=O)C=3C=CC=CC=3)C2=CC=C1 HSTXWFCGRUJCET-UHFFFAOYSA-N 0.000 description 1
- JPSMTGONABILTP-UHFFFAOYSA-N 4-(4-hydroxy-3,5-dimethylphenyl)sulfanyl-2,6-dimethylphenol Chemical compound CC1=C(O)C(C)=CC(SC=2C=C(C)C(O)=C(C)C=2)=C1 JPSMTGONABILTP-UHFFFAOYSA-N 0.000 description 1
- YNWRQXYZKFAPSH-UHFFFAOYSA-N 4-(4-hydroxy-3,5-dimethylphenyl)sulfinyl-2,6-dimethylphenol Chemical compound CC1=C(O)C(C)=CC(S(=O)C=2C=C(C)C(O)=C(C)C=2)=C1 YNWRQXYZKFAPSH-UHFFFAOYSA-N 0.000 description 1
- SUCTVKDVODFXFX-UHFFFAOYSA-N 4-(4-hydroxy-3,5-dimethylphenyl)sulfonyl-2,6-dimethylphenol Chemical compound CC1=C(O)C(C)=CC(S(=O)(=O)C=2C=C(C)C(O)=C(C)C=2)=C1 SUCTVKDVODFXFX-UHFFFAOYSA-N 0.000 description 1
- RQCACQIALULDSK-UHFFFAOYSA-N 4-(4-hydroxyphenyl)sulfinylphenol Chemical compound C1=CC(O)=CC=C1S(=O)C1=CC=C(O)C=C1 RQCACQIALULDSK-UHFFFAOYSA-N 0.000 description 1
- IKQWMLALTXOOGU-UHFFFAOYSA-N 4-[(4-hydroxy-2,6-dimethylphenyl)methyl]-3,5-dimethylphenol Chemical compound CC1=CC(O)=CC(C)=C1CC1=C(C)C=C(O)C=C1C IKQWMLALTXOOGU-UHFFFAOYSA-N 0.000 description 1
- BATCUENAARTUKW-UHFFFAOYSA-N 4-[(4-hydroxyphenyl)-diphenylmethyl]phenol Chemical compound C1=CC(O)=CC=C1C(C=1C=CC(O)=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 BATCUENAARTUKW-UHFFFAOYSA-N 0.000 description 1
- BUGLKPUHRTVBDI-UHFFFAOYSA-N 4-[1-(4-hydroxy-3,5-dimethylphenyl)-1-phenylethyl]-2,6-dimethylphenol Chemical compound CC1=C(O)C(C)=CC(C(C)(C=2C=CC=CC=2)C=2C=C(C)C(O)=C(C)C=2)=C1 BUGLKPUHRTVBDI-UHFFFAOYSA-N 0.000 description 1
- SVOBELCYOCEECO-UHFFFAOYSA-N 4-[1-(4-hydroxy-3-methylphenyl)cyclohexyl]-2-methylphenol Chemical compound C1=C(O)C(C)=CC(C2(CCCCC2)C=2C=C(C)C(O)=CC=2)=C1 SVOBELCYOCEECO-UHFFFAOYSA-N 0.000 description 1
- BHWMWBACMSEDTE-UHFFFAOYSA-N 4-[1-(4-hydroxyphenyl)cyclododecyl]phenol Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)CCCCCCCCCCC1 BHWMWBACMSEDTE-UHFFFAOYSA-N 0.000 description 1
- OVVCSFQRAXVPGT-UHFFFAOYSA-N 4-[1-(4-hydroxyphenyl)cyclopentyl]phenol Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)CCCC1 OVVCSFQRAXVPGT-UHFFFAOYSA-N 0.000 description 1
- PCAOSZNSMXPEQE-UHFFFAOYSA-N 4-[2-(4-hydroxy-2-phenylphenyl)propan-2-yl]-3-phenylphenol Chemical compound C=1C=C(O)C=C(C=2C=CC=CC=2)C=1C(C)(C)C1=CC=C(O)C=C1C1=CC=CC=C1 PCAOSZNSMXPEQE-UHFFFAOYSA-N 0.000 description 1
- ODJUOZPKKHIEOZ-UHFFFAOYSA-N 4-[2-(4-hydroxy-3,5-dimethylphenyl)propan-2-yl]-2,6-dimethylphenol Chemical compound CC1=C(O)C(C)=CC(C(C)(C)C=2C=C(C)C(O)=C(C)C=2)=C1 ODJUOZPKKHIEOZ-UHFFFAOYSA-N 0.000 description 1
- BKTRENAPTCBBFA-UHFFFAOYSA-N 4-[2-(4-hydroxy-3-phenylphenyl)propan-2-yl]-2-phenylphenol Chemical compound C=1C=C(O)C(C=2C=CC=CC=2)=CC=1C(C)(C)C(C=1)=CC=C(O)C=1C1=CC=CC=C1 BKTRENAPTCBBFA-UHFFFAOYSA-N 0.000 description 1
- WOCGGVRGNIEDSZ-UHFFFAOYSA-N 4-[2-(4-hydroxy-3-prop-2-enylphenyl)propan-2-yl]-2-prop-2-enylphenol Chemical compound C=1C=C(O)C(CC=C)=CC=1C(C)(C)C1=CC=C(O)C(CC=C)=C1 WOCGGVRGNIEDSZ-UHFFFAOYSA-N 0.000 description 1
- ADHQFDNEARRZPH-UHFFFAOYSA-N 4-[4-(4-hydroxyphenyl)-3-bicyclo[2.2.1]heptanyl]phenol Chemical compound C1=CC(O)=CC=C1C1C(C=2C=CC(O)=CC=2)(C2)CCC2C1 ADHQFDNEARRZPH-UHFFFAOYSA-N 0.000 description 1
- GAIZUCZZMVHBQO-UHFFFAOYSA-N 4-[4-[4-(4-hydroxyphenoxy)phenyl]phenoxy]phenol Chemical group C1=CC(O)=CC=C1OC1=CC=C(C=2C=CC(OC=3C=CC(O)=CC=3)=CC=2)C=C1 GAIZUCZZMVHBQO-UHFFFAOYSA-N 0.000 description 1
- NUDSREQIJYWLRA-UHFFFAOYSA-N 4-[9-(4-hydroxy-3-methylphenyl)fluoren-9-yl]-2-methylphenol Chemical compound C1=C(O)C(C)=CC(C2(C3=CC=CC=C3C3=CC=CC=C32)C=2C=C(C)C(O)=CC=2)=C1 NUDSREQIJYWLRA-UHFFFAOYSA-N 0.000 description 1
- BPMBNLJJRKCCRT-UHFFFAOYSA-N 4-phenylbenzonitrile Chemical compound C1=CC(C#N)=CC=C1C1=CC=CC=C1 BPMBNLJJRKCCRT-UHFFFAOYSA-N 0.000 description 1
- YWFPGFJLYRKYJZ-UHFFFAOYSA-N 9,9-bis(4-hydroxyphenyl)fluorene Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C2=CC=CC=C21 YWFPGFJLYRKYJZ-UHFFFAOYSA-N 0.000 description 1
- 101100192215 Arabidopsis thaliana PTAC7 gene Proteins 0.000 description 1
- HTVITOHKHWFJKO-UHFFFAOYSA-N Bisphenol B Chemical compound C=1C=C(O)C=CC=1C(C)(CC)C1=CC=C(O)C=C1 HTVITOHKHWFJKO-UHFFFAOYSA-N 0.000 description 1
- GIXXQTYGFOHYPT-UHFFFAOYSA-N Bisphenol P Chemical compound C=1C=C(C(C)(C)C=2C=CC(O)=CC=2)C=CC=1C(C)(C)C1=CC=C(O)C=C1 GIXXQTYGFOHYPT-UHFFFAOYSA-N 0.000 description 1
- SDDLEVPIDBLVHC-UHFFFAOYSA-N Bisphenol Z Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)CCCCC1 SDDLEVPIDBLVHC-UHFFFAOYSA-N 0.000 description 1
- 241001285221 Breviceps Species 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- SUAKHGWARZSWIH-UHFFFAOYSA-N N,N‐diethylformamide Chemical compound CCN(CC)C=O SUAKHGWARZSWIH-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920002614 Polyether block amide Polymers 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- LLJNTLUXOZPFQB-UHFFFAOYSA-N [4-(4-fluorobenzoyl)phenyl]-(4-fluorophenyl)methanone Chemical compound C1=CC(F)=CC=C1C(=O)C1=CC=C(C(=O)C=2C=CC(F)=CC=2)C=C1 LLJNTLUXOZPFQB-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910001513 alkali metal bromide Inorganic materials 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 229910001508 alkali metal halide Inorganic materials 0.000 description 1
- 150000008045 alkali metal halides Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000012296 anti-solvent Substances 0.000 description 1
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 1
- 238000010533 azeotropic distillation Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- VCCBEIPGXKNHFW-UHFFFAOYSA-N biphenyl-4,4'-diol Chemical compound C1=CC(O)=CC=C1C1=CC=C(O)C=C1 VCCBEIPGXKNHFW-UHFFFAOYSA-N 0.000 description 1
- ZFVMWEVVKGLCIJ-UHFFFAOYSA-N bisphenol AF Chemical compound C1=CC(O)=CC=C1C(C(F)(F)F)(C(F)(F)F)C1=CC=C(O)C=C1 ZFVMWEVVKGLCIJ-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- ZMCUDHNSHCRDBT-UHFFFAOYSA-M caesium bicarbonate Chemical compound [Cs+].OC([O-])=O ZMCUDHNSHCRDBT-UHFFFAOYSA-M 0.000 description 1
- LYQFWZFBNBDLEO-UHFFFAOYSA-M caesium bromide Chemical compound [Br-].[Cs+] LYQFWZFBNBDLEO-UHFFFAOYSA-M 0.000 description 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- HUCVOHYBFXVBRW-UHFFFAOYSA-M caesium hydroxide Inorganic materials [OH-].[Cs+] HUCVOHYBFXVBRW-UHFFFAOYSA-M 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- CCAFPWNGIUBUSD-UHFFFAOYSA-N diethyl sulfoxide Chemical compound CCS(=O)CC CCAFPWNGIUBUSD-UHFFFAOYSA-N 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 229940037395 electrolytes Drugs 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 125000003827 glycol group Chemical group 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- KEDRKJFXBSLXSI-UHFFFAOYSA-M hydron;rubidium(1+);carbonate Chemical compound [Rb+].OC([O-])=O KEDRKJFXBSLXSI-UHFFFAOYSA-M 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 description 1
- 229910052808 lithium carbonate Inorganic materials 0.000 description 1
- 229910000032 lithium hydrogen carbonate Inorganic materials 0.000 description 1
- HQRPHMAXFVUBJX-UHFFFAOYSA-M lithium;hydrogen carbonate Chemical compound [Li+].OC([O-])=O HQRPHMAXFVUBJX-UHFFFAOYSA-M 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- AJFDBNQQDYLMJN-UHFFFAOYSA-N n,n-diethylacetamide Chemical compound CCN(CC)C(C)=O AJFDBNQQDYLMJN-UHFFFAOYSA-N 0.000 description 1
- IFTIBNDWGNYRLS-UHFFFAOYSA-N n,n-dipropylacetamide Chemical compound CCCN(C(C)=O)CCC IFTIBNDWGNYRLS-UHFFFAOYSA-N 0.000 description 1
- PZYDAVFRVJXFHS-UHFFFAOYSA-N n-cyclohexyl-2-pyrrolidone Chemical compound O=C1CCCN1C1CCCCC1 PZYDAVFRVJXFHS-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000002825 nitriles Chemical group 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- QBDSZLJBMIMQRS-UHFFFAOYSA-N p-Cumylphenol Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=CC=C1 QBDSZLJBMIMQRS-UHFFFAOYSA-N 0.000 description 1
- NKTOLZVEWDHZMU-UHFFFAOYSA-N p-cumyl phenol Natural products CC1=CC=C(C)C(O)=C1 NKTOLZVEWDHZMU-UHFFFAOYSA-N 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- IVXQBCUBSIPQGU-UHFFFAOYSA-N piperazine-1-carboxamide Chemical group NC(=O)N1CCNCC1 IVXQBCUBSIPQGU-UHFFFAOYSA-N 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920000765 poly(2-oxazolines) Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000412 polyarylene Polymers 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 229920005597 polymer membrane Polymers 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000003361 porogen Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- WPFGFHJALYCVMO-UHFFFAOYSA-L rubidium carbonate Chemical compound [Rb+].[Rb+].[O-]C([O-])=O WPFGFHJALYCVMO-UHFFFAOYSA-L 0.000 description 1
- 229910000026 rubidium carbonate Inorganic materials 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000002076 thermal analysis method Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/06—Organic material
- B01D71/66—Polymers having sulfur in the main chain, with or without nitrogen, oxygen or carbon only
- B01D71/68—Polysulfones; Polyethersulfones
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/02—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor characterised by their properties
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/08—Hollow fibre membranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2323/00—Details relating to membrane preparation
- B01D2323/12—Specific ratios of components used
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2323/00—Details relating to membrane preparation
- B01D2323/36—Introduction of specific chemical groups
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2325/00—Details relating to properties of membranes
- B01D2325/18—Membrane materials having mixed charged functional groups
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2325/00—Details relating to properties of membranes
- B01D2325/34—Molecular weight or degree of polymerisation
Definitions
- This disclosure relates generally to polymer blends used for making hollow fiber membranes.
- the polymer blends comprise at least one polymer comprising zwitterionic groups.
- Porous hollow-fiber polymeric membranes are employed in many applications such as hemodialysis, ultrafiltration, nanofiltration, reverse osmosis, gas separation, microfiltration, and pervaporation. For many of these applications, membranes with optimal selectivity as well as chemical, thermal and mechanical stability are desirable. In many applications (for example, bio-separation or water filtration) it may also be desirable to have membranes with one or more of improved hydrophilicity, improved biocompatibility, or low fouling.
- Polyarylene ethers in particular, polyethersulfones and polysulfones are often used as membrane materials because of their mechanical, thermal, and chemical stability.
- these polymers are hydrophobic and lack the biocompatibility and hydrophilicity required for aqueous applications. Improvements in membrane hydrophilicity have been achieved by polymer blending, for example, fabricating the porous membrane in the presence of small amounts of hydrophilic polymers such as polyvinylpyrollidone (PVP).
- PVP polyvinylpyrollidone
- hydrophilicity has been achieved via functionalization of the polymer backbone and introduction of carboxyl, nitrile or polyethylene glycol functionality.
- polymer blends which alleviate certain limitations of previously known methods for the manufacture of hollow fiber membranes.
- the present blends increase processability of functionalized polymers and also reduce the need for post-casting functionalization of membranes.
- hollow-fiber membranes comprising a blend of a first polymer comprising a sulfone polymer having zwitterionic functionality and a second polymer comprising a sulfone polymer:
- hollow-fiber membranes comprising a blend of a first polymer comprising a sulfone polymer having zwitterionic functionality and a second polymer comprising a sulfone polymer, wherein the first polymer comprising a sulfone polymer having zwitterionic functionality comprises structural units of formula IA or formula IB attached to structural units of formula II and wherein the second polymer comprising a sulfone polymer comprises structural units having the structure of formula II, III, IV, or V, wherein the structures of formula IA, IB, II, III, IV, and V are as described in the detailed description section below.
- FIG. 1 shows a comparison between a cross section of a hollow fiber membrane comprising high molecular weight polymers and a hollow fiber membrane comprising the instantly claimed polymer blends.
- FIG. 2 shows a comparison between protein binding properties (fouling) of hollow fiber membranes: (1) high molecular weight polysulfone (PSU) (MW 54 kg/mol) ultrafiltration hollow fiber membrane, (2) high molecular weight polysulfone (PSU) (MW 54 kg/mol) microfiltration hollow fiber membrane, (3) PSU comprising zwitterionic groups (ZwPSU) microfiltration hollow fiber membrane, (4) microfiltration hollow fiber membrane comprising the present polymer blends (MW ⁇ 49.3kg/mol), and (5) PSU comprising zwitterionic groups (ZwPSU) microfiltration hollow fiber membrane.
- PSU high molecular weight polysulfone
- PSU high molecular weight polysulfone
- Hollow fiber membranes are typically employed in applications where a hydrophilic and/or biocompatible barrier is required.
- Zwitterionic sulfone polymers are hydrophilic and cause low protein binding and biofouling.
- zwitterionic sulfone polymers tend to be difficult to process into membranes, and the resulting membranes often have poor mechanical properties.
- Previous attempts at improving hydrophilicity of sulfone-polymer-containing membranes have focused on post- fabrication functionalization of polymers and/or membranes.
- novel blends of polymers comprising sulfone polymers and zwitterionic sulfone polymers which alleviate the need for post- fabrication functionalization of membranes.
- the polymeric blends described herein can improve polymer network structure and result in better mechanical performance.
- the polymer blends described herein also confer improved processability allowing for easier manufacture of membranes, including hollow fiber membranes.
- the polymer blends described herein provide the desired hydrophilicity and/or biocompatibility to the membranes.
- the mechanical properties of membranes comprising said polymeric blends are significantly improved while maintaining membrane morphology and low binding characteristics of the membranes.
- the present membranes alleviate problems associated with leaching of water soluble polymers such as PVP from the matrix, thereby reducing product variability.
- the polymer blends described herein provide easy adjustment and significant improvement of membrane processibility (e.g. low dope viscosity) and mechanical property (e.g. high tensile elongation), and also provide some cost reduction by replacing expensive zwitterionic sulfone polymers with less expensive sulfone polymers in the blends.
- membrane processibility e.g. low dope viscosity
- mechanical property e.g. high tensile elongation
- Approximating language may be applied to modify any quantitative representation that could permissibly vary without resulting in a change in the basic function to which it is related. Accordingly, a value modified by a term or terms, such as “about”, and “substantially” is not to be limited to the precise value specified. In some instances, the approximating language may correspond to the precision of an instrument for measuring the value.
- range limitations may be combined and/or interchanged, such ranges are identified and include all the sub-ranges contained therein unless context or language indicates otherwise.
- the singular forms "a”, “an” and “the” include plural referents unless the context clearly dictates otherwise.
- the term “or” is not meant to be exclusive and refers to at least one of the referenced components being present and includes instances in which a combination of the referenced components may be present, unless the context clearly dictates otherwise.
- sulfone polymer is any polymer comprising one or more subunits of structure aryl-SC -aryl. Typically sulfone polymers are prepared via a reaction between a diphenol and a bis(4-chlorophenyl)sulfone by elimination of sodium chloride: Sulfone polymers include and are not limited to polysulfones, polyarylsulfones (alternatively referred to as polyphenylsulfones, or polypheny lenesulf ones), poly ethersulf ones, and the like.
- sulfone polymer having zwitterionic functionality or a “zwitterionic sulfone polymer” is any polymer comprising one or more subunits of structure aryl-SC -aryl and having one or more subunits comprising zwitterionic functionality.
- the term "hollow-fiber membrane” as used herein refers to fiber-based membrane structures including separating layers present at the surface.
- the hollow- fiber membrane may function using "inside-outside” or “outside-inside” mechanism.
- the terms “hollow-fiber membrane” and “membrane” are used herein interchangeably, unless the context clearly indicates otherwise.
- alkyl refers to a straight- or branched-chain alkyl group having from 1 to 12 carbon atoms in the chain.
- alkyl groups include methyl (Me) ethyl (Et), n-propyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl (tBu), pentyl, isopentyl, tert-pentyl, hexyl, isohexyl, and the like.
- Cycloalkyl refers to monocyclic or polycyclic non-aromatic hydrocarbon groups having from 3 to 12 carbon atoms.
- Non-limiting of cycloalkyl groups include, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, 1-methylcyclopropyl, 2- methylcyclopentyl, octahydro-lH-indene, decahydronaphthalene, and the like.
- aryl represents a mono- or bi-cyclic aromatic, hydrocarbon ring structure. Aryl rings can have 6 or 10 carbon atoms in the ring.
- hollow-fiber membranes comprising a blend of a first polymer comprising a sulfone polymer having zwitterionic functionality and a second polymer comprising a sulfone polymer.
- hollow-fiber membranes comprising a blend of a first polymer comprising a sulfone polymer having zwitterionic functionality and a second polymer comprising a sulfone polymer wherein the first polymer comprising a sulfone polymer having zwitterionic functionality comprises structural units of formula IA or formula
- R 1 and R 2 are independently at each occurrence a hydrogen atom, a halogen atom, a nitro group, a C1-C12 alkyl, a C3-C12 cycloalkyl, or an aryl ring; k is from 0 to 10;
- Y' and R' are each, independently, hydrogen, C1-C20 alkyl, or an aryl ring;
- R 4 is a bond, a C1-C12 alkyl, a C3-C12 cycloalkyl, or an aryl ring;
- R 5 and R 6 are independently at each occurrence a hydrogen atom, a halogen atom, a nitro group, a C1-C12 alkyl, a C3-C12 cycloalkyl, or an aryl ring;
- n are each, independently, 0 or 1.
- hollow-fiber membranes comprising a blend of a first polymer comprising a sulfone polymer having zwitterionic functionality and a second polymer comprising a sulfone polymer, wherein the second polymer comprising a sulfone polymer comprises structural units having the structure of formula II, III IV, or
- R 5 and R 6 are independently at each occurrence a hydrogen atom, a halogen atom, a nitro group, a C1-C12 alkyl, a C3-C12 cycloalkyl, or an aryl ring;
- Y' and R' are each, independently, hydrogen, C1-C20 alkyl, or an aryl ring; a and b are independently at each occurrence 0, 1, 2, 3, or 4; and m and n are each, independently, 0 or 1.
- the first polymer comprising a sulfone polymer having zwitterionic functionality comprises structural units of formula IA or formula IB attached to structural units of formula II:
- R 1 and R 2 are independently at each occurrence a hydrogen atom, a halogen atom, a nitro group, a C1-C12 alkyl, a C3-C12 cycloalkyl, or an aryl ring; k is from 0 to 10;
- Y' and R' are each, independently, hydrogen, C1-C20 alkyl, or an aryl ring;
- R 4 is a bond, a C1-C12 alkyl, a C3-C12 cycloalkyl, or an aryl ring;
- R 5 and R 6 are independently at each occurrence a hydrogen atom, a halogen atom, a nitro group, a C1-C12 alkyl, a C3-C12 cycloalkyl, or an aryl ring; and Y' and R' are each, independently, hydrogen, C1-C20 alkyl, or an aryl ring; a, a' and b are independently at each occurrence 0, 1, 2, 3, or 4; m and n are each, independently, 0 or 1 ; and
- the second polymer comprising a sulfone polymer comprises structural units having the structure of formula II, IV, or V
- the first polymer comprising a sulfone polymer having zwitterionic functionality comprises structural units of formula VI:
- w 0, 1, 2, or 3.
- the first polymer comprising a sulfone polymer having zwitterionic functionality comprises
- the mole fraction of the zwitterion-functionalized structural units of formula IB in the first polymer is less than about 50 mole percent of the total moles of the units of formula IB and formula II in the first polymer. In some embodiments of the hollow fiber membranes described above, the mole fraction of the zwitterion-functionalized structural units of formula IB in the first polymer is in a range from about 30 mole percent to about 50 mole percent of the total moles of the units of formula IB and formula II in the first polymer.
- the molecular weight of the first polymer comprising a sulfone polymer having zwitterionic functionality is in a range from about 10000 g/mol to about 80000 g/mol.
- the second polymer comprising a sulfone polymer comprises a polysulfone comprising structural units of formula II.
- the second polymer comprising a sulfone polymer comprises a polyphenyl sulfone comprising structural units of formula IV.
- the second polymer comprising a sulfone polymer comprises a polyethersulfone comprising structural units of formula V.
- the second polymer comprising a sulfone polymer is in an amount from about 0.5 weight % to about 5 weight % of the total weight of polymer in the membrane.
- the molecular weight of the second polymer comprising a sulfone polymer is in a range from about 50000 g/mol to about 80000 g/mol.
- the first polymer comprising a sulfone polymer having zwitterionic functionality comprises structural units of formula IB attached to structural units of formula II, and the second
- the first polymer comprising a sulfone polymer having zwitterionic functionality comprises structural units of formula IB attached to structural units of formula II, and the second
- the first polymer comprising a sulfone polymer having zwitterionic functionality comprises structural units of formula IB attached to structural units of formula II
- the second polymer comprising a sulfone polymer comprises structural units of formula V
- hollow-fiber membrane modules comprising a plurality of hollow-fiber membranes wherein the first polymer comprising a sulfone polymer having zwitterionic functionality comprises structural units of formula IB attached to structural units of formula II, and the second polymer comprising a sulfone polymer comprises structural units of formula II.
- a hemodialysis or hemofiltration apparatus comprising a hollow-fiber membrane module wherein the first polymer comprising a sulfone polymer having zwitterionic functionality comprises structural units of formula IB attached to structural units of formula II, and the second polymer comprising a sulfone polymer comprises structural units of formula II.
- hollow-fiber membrane modules comprising a plurality of hollow-fiber membranes wherein the first polymer comprising a sulfone polymer having zwitterionic functionality comprises structural units of formula IB attached to structural units of formula II, and the second polymer comprising a sulfone polymer comprises structural units of formula IV.
- a hemodialysis or hemofiltration apparatus comprising a hollow-fiber membrane module wherein the first polymer comprising a sulfone polymer having zwitterionic functionality comprises structural units of formula IB attached to structural units of formula II, and the second polymer comprising a sulfone polymer comprises structural units of formula IV.
- hollow-fiber membrane modules comprising a plurality of hollow-fiber membranes wherein the first polymer comprising a sulfone polymer having zwitterionic functionality comprises structural units of formula IB attached to structural units of formula II, and the second polymer comprising a sulfone polymer comprises structural units of formula V.
- a hemodialysis or hemofiltration apparatus comprising a hollow-fiber membrane module wherein the first polymer comprising a sulfone polymer having zwitterionic functionality comprises structural units of formula IB attached to structural units of formula II, and the second polymer comprising a sulfone polymer comprises structural units of formula V.
- composition comprising a blend of a first polymer comprising a sulfone polymer having zwitterionic functionality and a second polymer comprising a sulfone polymer.
- composition comprising a blend of a first polymer comprising a sulfone polymer having zwitterionic functionality and a second polymer comprising a sulfone polymer wherein the first polymer comprising a sulfone polymer having zwitterionic functionality comprises structural units of formula IB attached to structural units of formula II, and the second polymer comprising a
- R 1 and R 2 are independently at each occurrence a hydrogen atom, a halogen atom, a nitro group, a C1-C12 alkyl, a C3-C12 cycloalkyl, or an aryl ring; k is from 0 to 10;
- R 3 and Y are independently a hydrogen atom, a C1-C12 alkyl, a C3-C12 cycloalkyl, or an aryl ring;
- R 4 is a bond, a C1-C12 alkyl, a C3-C12 cycloalkyl, or an aryl ring;
- R 5 and R 6 are independently at each occurrence a hydrogen atom, a halogen atom, a nitro group, a C1-C12 alkyl, a C3-C12 cycloalkyl, or an aryl ring; a, a' and b are independently at each occurrence 0, 1, 2, 3, or 4; and m and n are each, independently, 0 or 1.
- composition comprising a blend of a first polymer comprising a sulfone polymer having zwitterionic functionality and a second polymer comprising a sulfone polymer wherein the first polymer comprising a sulfone polymer having zwitterionic functionality comprises structural units of formula IB attached to structural units of formula II, and the second polymer comprising a sulfone polymer comprises structural units of formula IV
- R 1 and R 2 are independently at each occurrence a hydrogen atom, a halogen atom, a nitro group, a C1-C12 alkyl, a C3-C12 cycloalkyl, or an aryl ring;
- k is from 0 to 10;
- R 3 and Y are independently a hydrogen atom, a C1-C12 alkyl, a C3-C12 cycloalkyl, or an aryl ring;
- R 4 is a bond, a C1-C12 alkyl, a C3-C12 cycloalkyl, or an aryl ring;
- R 5 and R 6 are independently at each occurrence a hydrogen atom, a halogen atom, a nitro group, a C1-C12 alkyl, a C3-C12 cycloalkyl, or an aryl ring;
- a, a' and b are independently at each occurrence 0, 1, 2, 3, or 4; and m and n are each, independently, 0 or 1.
- composition comprising a blend of a first polymer comprising a sulfone polymer having zwitterionic functionality and a second polymer comprising a sulfone polymer wherein the first polymer comprising a sulfone polymer having zwitterionic functionality comprises structural units of formula IB attached to structural units of formula II, and the second polymer comprising a
- R 1 and R 2 are independently at each occurrence a hydrogen atom, a halogen atom, a nitro group, a C1-C12 alkyl, a C3-C12 cycloalkyl, or an aryl ring; k is from 0 to 10;
- R 3 and Y are independently a hydrogen atom, a C1-C12 alkyl, a C3-C12 cycloalkyl, or an aryl ring;
- R 4 is a bond, a C1-C12 alkyl, a C3-C12 cycloalkyl, or an aryl ring;
- R 5 and R 6 are independently at each occurrence a hydrogen atom, a halogen atom, a nitro group, a C1-C12 alkyl, a C3-C12 cycloalkyl, or an aryl ring; a, a' and b are independently at each occurrence 0, 1, 2, 3, or 4; and m and n are each, independently, 0 or 1.
- the casting solution may have a total polymer content in the casting solution which is less than about 50% by weight of the casting solution. In additional embodiments, the casting solution may have a total polymer content in the casting solution which is between about 10% and about 30% by weight of the casting solution. It will be understood that the actual content of polymers in the membrane may not always be identical to the amount of polymers in the casting solution (dope). By way of illustration only, a 2.5 weight% sulfone polymer (second polymer) content in the membrane may arise from 0.4 weight% sulfone polymer in the casting solution along with 15.6 weight% of the sulfone polymer comprising zwitterionic functionality in the casting solution.
- the hollow-fiber membrane which is formed from step (B) above comprises the second polymer in an amount from about 0.5 weight % to about 5 weight % of the total weight of polymer in the membrane. In other embodiments, the hollow-fiber membrane which is formed from step (B) above comprises the second polymer in an amount from about 0.5 weight % to about 3 weight % of the total weight of polymer in the membrane.
- the sulfone polymers and/or the sulfone polymers having zwitterionic functionality described herein are synthesized using any suitable techniques known in the art. In certain embodiments, the sulfone polymer are synthesized by reacting at least one aromatic dihydroxy compound with at least one aromatic dihalide compound.
- At least one of the aromatic dihydroxy compound and the aromatic dihalide compound may be functionalized with a suitable functional group (for example, piperazine amide group) capable of being converted to the zwitterion functional group.
- the aromatic dihydroxy compound may be functionalized with a suitable functional group.
- at least one of the aromatic dihydroxy compound and the aromatic dihalide compound may include a sulfone moiety.
- the aromatic dihalide compound may include the sulfone moiety.
- Exemplary aromatic dihalide compounds that may be used include 4,4'- bis(chlorophenyl)sulfone, 2,4'-bis(chlorophenyl)sulfone, 2,4- bis(chlorophenyl)sulfone, 4,4'-bis(fluorophenyl)sulfone, 2,4'-bis(fluorophenyl)sulfone, 2,4-bis(fluorophenyl)sulfone, 4,4'-bis(chlorophenyl)sulfoxide, 2,4-bis(chlorophenyl)sulfoxide, 4,4'- bis(fluorophenyl)sulfoxide, 2,4'-bis(fluorophenyl)sulfoxide, 2,4- bis(fluorophenyl)sulfoxide, 4,4'-bis(fluorophenyl)ketone, 2,4'- bis(fluoropheny
- Non-limiting examples of suitable aromatic dihydroxy compounds include 4,4'-dihydroxyphenyl sulfone, 2,4'-dihydroxyphenyl sulfone, 4,4'- dihydroxyphenyl sulfoxide, 2,4'-dihydroxyphenyl sulfoxide, bis(3,5-dimethyl-4- hydroxyphenyl) sulfoxide, bis(3,5-dimethyl-4-hydroxyphenyl) sulfone, 4,4- (phenylphosphinyl)diphenol, 4,4'-oxydiphenol,4,4'-thiodiphenol, 4,4'- dihydroxybenzophenone, 4,4'dihydroxyphenylmethane, hydroquinone, resorcinol, 5- cyano- 1 ,3-dihydroxybenzene, 4-cyano- 1 ,3,-dihydroxybenzene, 2-cyano- 1 ,4- dihydroxybenzene, 2-methoxyhydroquinone,
- the reaction may be effected in a polar aprotic solvent in the presence of an alkali metal compound, and optionally, in the presence of catalysts.
- a basic salt of an alkali metal compound may be used to effect the reaction between the dihalo and dihydroxy aromatic compounds.
- Exemplary compounds include alkali metal hydroxides, such as, but not limited to, lithium hydroxide, sodium hydroxide, potassium hydroxide, rubidium hydroxide, and cesium hydroxide; alkali metal carbonates, such as, but not limited to, lithium carbonate, sodium carbonate, potassium carbonate, rubidium carbonate, and cesium carbonate; and alkali metal hydrogen carbonates, such as but not limited to lithium hydrogen carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate, rubidium hydrogen carbonate, and cesium hydrogen carbonate. Combinations of these compounds may also be used to effect the reaction.
- alkali metal hydroxides such as, but not limited to, lithium hydroxide, sodium hydroxide, potassium hydroxide, rubidium hydroxide, and cesium hydroxide
- alkali metal carbonates such as, but not limited to, lithium carbonate, sodium carbonate, potassium carbonate, rubidium carbonate, and cesium carbonate
- alkali metal hydrogen carbonates such as but not limited to lithium hydrogen carbonate, sodium hydrogen carbonate
- aprotic polar solvents include and are not limited to N,N- dimethylformamide, N,N-diethylformamide, ⁇ , ⁇ -dimethylacetamide, N,N- diethylacetamide, N,N-dipropylacetamide, ⁇ , ⁇ -dimethylbenzamide, N-methyl-2- pyrrolidone (NMP), N-ethyl-2-pyrrolidone, N-isopropyl-2-pyrrolidone, N-isobutyl-2- pyrrolidone, N-n-propyl-2-pyrrolidone, N-n-butyl-2-pyrrolidone, N-cyclohexyl-2- pyrrolidone, N-methyl-3-methyl-2-pyrrolidone, N-ethyl-3-methyl-pyrrolidone, N- methyl-3,4,5-trimethyl-2-pyrrolidone, N-methyl-2-piperidone, N-ethyl-2-pyrrol
- the reaction may be conducted at a temperature in a range from about 100°C to about 300°C in some embodiments, from about 120°C to about 200°C in some embodiments, and from about 150°C to about 200°C in particular embodiments.
- the reaction mixture may be further dried by addition to the initial reaction mixture of, along with the polar aprotic solvent, a solvent that forms an azeotrope with water.
- solvents include toluene, benzene, xylene, ethylbenzene and chlorobenzene. After removal of residual water by azeotropic drying, the reaction may be carried out at the elevated temperatures described above.
- the reaction is typically conducted for a time period ranging from about 1 hour to about 72 hours in some embodiments, and from about 1 hour to about 10 hours in particular embodiments.
- the polymer may be separated from the inorganic salts, precipitated into a non-solvent and collected by filtration and drying.
- non-solvents include water, methanol, ethanol, propanol, butanol, acetone, methyl ethyl ketone, methyl isobutyl ketone, and combinations thereof.
- the glass transition temperature, T g , of the polymers described herein may be in a range from about 120°C to about 280°C in one embodiment, and may be in a range from about 140°C to about 200°C in another embodiment.
- the polymers may be further characterized by the weight average molecular weight (M w ) obtained from gel permeation chromatography based on polystyrene standards.
- M w weight average molecular weight
- the Mw of the polymer may be in the range from about 10000 grams per mole (g/mol) to about 100000 g/mol.
- the M w may be in a range from about 10000 g/mol to about 75000 g/mol.
- the M w may be in a range from about 40000 g/mol to about 55000 g/mol. In a further embodiment, the M w may be in a range from about 50000 g/mol to about 80000 g/mol.
- the polymers and the membranes including the blended polymers described herein may be further characterized by their respective hydrophilicities.
- the sulfone polymer having zwitterionic functionality has a contact angle with water less than about 80 degrees measured on a surface of the polymer cast as a film on a glass substrate.
- the sulfone polymer having zwitterionic functionality has a contact angle with water less than about 50 degrees measured on a surface of the polymer cast as a film on a glass substrate.
- the sulfone polymer having zwitterionic functionality has a contact angle with water less than about 30 degrees measured on a surface of the polymer cast as a film on a glass substrate.
- the membranes in accordance with embodiments described herein are made by processes known in the art. Suitable techniques include, but are not limited to: dry- phase separation membrane formation process; wet-phase separation membrane formation process; dry-wet phase separation membrane formation process; thermally- induced phase-separation membrane formation process. Further, post membrane- formation, the membrane may be subjected to a membrane conditioning process or a treatment process prior to its use in a separation application. Representative processes may include thermal annealing to relieve stresses or pre-equilibration in a solution similar to the feed stream the membrane will contact.
- the membranes may be prepared by phase inversion.
- the phase inversion process includes 1) vapor-induced phase separation (VIPS), also called “dry casting” or “air casting”; 2) liquid- induced phase separation (LIPS), mostly referred to as “immersion casting” or “wet casting”; and 3) thermally induced phase separation (TIPS), frequently called “melt casting”.
- VIPS vapor-induced phase separation
- LIPS liquid- induced phase separation
- TIPS thermally induced phase separation
- the phase inversion process can produce integrally skinned asymmetric membranes.
- the membranes may be cross-linked to provide additional support.
- the membrane may be designed and fabricated to have specific pore sizes so that solutes having sizes greater than the pore sizes may not be able to pass through.
- the pore size may be in a range from about 0.5 nanometers to about 100 nanometers. In another embodiment, the pore size may be in a range from about 1 nanometer to about 25 nm.
- a method of forming a hollow-fiber membrane described herein includes providing a casting solution comprising the polymer blend as described earlier and a solvent. The method further includes extruding the casting solution through an annular channel to form the hollow-fiber membrane.
- suitable solvents include N-methyl-2-pyrrolidone, dimethylacetamide, dimethylformamide, tetrahydrofuran, methyl ethyl ketone, formylpiperidine, or combinations thereof.
- the casting solution may further include an additive selected from the group consisting of polymers, such as, polyvinylpyrrolidone and polyethylene glycol; anti-solvents, such as, water, alcohols, glycols, glycol ethers, and salts; alkali metal halides; and combinations thereof.
- the additive may include an alkali metal bromide, such as, but not limited to, lithium bromide, sodium bromide, potassium bromide, cesium bromide, or combinations thereof.
- the additive may be present in the casting solution in an amount (total amount) in a range from about 0.1 weight percent to about 30 weight percent, in some embodiments. Further, the sulfone polymer and the sulfone polymer comprising zwitterionic functionality are present in the casting solution in an amount in a range from about 10 weight percent to about 30 weight percent of the weight of the casting solution.
- any hollow fiber membrane blend described above includes at least one additional polymer.
- the additional polymer may be blended with the polymer blend described above to impart different properties such as better heat resistance, biocompatibility, and the like.
- the additional polymer may be added to the casting solution during the membrane formation to modify the morphology of the phase inverted membrane structure produced upon phase inversion, such as asymmetric membrane structures.
- the additional polymer may be a sulfone polymer which persists in the final membrane and/or an additive (e.g., PVP, PEG and the like) which is lost in the fabrication process but is not completely removed.
- an additive e.g., PVP, PEG and the like
- the additional polymer blended is a hydrophilic polymer.
- suitable hydrophilic polymers include polyvinylpyrrolidone (PVP), polyoxazoline, polyethyleneglycol, polypropylene glycol, polyglycolmonoester, polymer of polyethyleneglycol with polypropylene glycol, water-soluble cellulose derivative, polysorbate, polyethylene-polypropylene oxide polymer, polyethyleneimine, and combinations thereof.
- the casting solution blend may comprise additional polymers, such as, polyether urethane, polyamide, polyether-amide, polyacrylonitrile, and combinations thereof.
- the membranes described herein have use in various applications, such as, bio- separation, water purification, hemofiltration, hemodialysis, ultrafiltration, nanofiltration, gas separation, microfiltration, reverse osmosis, and pervaporation.
- the membranes may have applications in the biopharmaceutical and biomedical field where improved hydrophilicity and biocompatibility are desired.
- a hollow-fiber membrane for bio- separation is characterized in part by the protein binding.
- the hollow-fiber membranes provided herein have protein binding less than about 30 ng/cm A2 .
- the membrane is composed of a polymer blend as described herein.
- a bio- separation apparatus that includes a plurality of porous hollow fibers composed of the porous membranes provided herein.
- the membranes described herein are used for hemodialysis.
- Dialysis refers to a process effected by one or more membranes in which transport is driven primarily by pressure differences across the thickness of the one or more membrane.
- Hemodialysis refers to a dialysis process in which biologically undesired and/or toxic solutes, such as metabolites and by-products are removed from blood.
- Hemodialysis membranes are porous membranes permitting the passage of low molecular weight solutes, typically less than 5,000 Daltons, such as urea, creatinine, uric acid, electrolytes and water, yet preventing the passage of higher molecular weight proteins and blood cellular elements.
- Hemofiltration which more closely represents the filtration in the glomerulus of the kidney, requires even more permeable membranes allowing complete passage of solutes of molecular weight of less than 50,000 Daltons, and, in some cases, less than 20,000 Daltons
- the polymer blends described herein confer the desired mechanical properties so as to support the porous hollow-fiber membrane structure during manufacture and use.
- the polymer blends confer adequate thermal properties so as to reduce or prevent degradation during high temperature steam sterilization processes.
- the polymer blends and membranes have optimal biocompatibility, such that protein fouling is minimized and thrombosis of the treated blood does not occur.
- the mixture was heated and samples taken every two hours until the desired molecular weight was achieved (8-10 hrs).
- the reaction viscosity increased over the course of the run with the reaction showing an opaque greyish color.
- the reaction was diluted with 0.8 liters of NMP and cooled to 50°C 1,3-Propane sultone was then added (149.7g, 1.227 moles) and the reaction mixture gradually heated to 80°C.
- the reaction was complete in ⁇ 4hrs. Gradually after the addition is complete the reaction color lightens to an off- white slurry. Based on solution viscosity the reaction mixture may be diluted further.
- the mixture was then precipitated into 12.0 L of water using a high speed blender, producing a white precipitate.
- the precipitate was collected by filtration then re-slurried in 5.0 liters of warm water (40- 50°C) for 6 hours. The solid was collected by filtration. The resulting polymer was dried under vacuum initially at 50°C under a purge of nitrogen for 24 hrs then an additional 24 hrs at 80- 100°C under full vacuum to provide approximately 950 grams of polymer after drying ( ⁇ 95% recovery).
- Casting of hollow fiber membranes was carried out using methods known in the art and using methods described herein.
- Polymer blends were prepared by dissolving the polymers in a suitable solvent.
- Dope solutions for casting hollow fiber membranes were prepared by dissolving the polymer blends and any optional additives in a suitable solvent.
- Nonspecific protein binding was measured using an immunoglobulin protein labeled with a horse-radish peroxidase (HRP) functional group.
- HRP horse-radish peroxidase
- the PBS was replaced with 2 ml of a 10 ⁇ g/ml solution of HRP-protein. After 2 hours of soaking, the antibody solution was removed and the fibers were washed thoroughly with PBS.
- CPB citrate- phosphate buffer
- the CPB was replaced with 0.5 ml of a CPB-based solution containing 0.5 mg/ml o-phenylenediamine (OPD) and 0.015% hydrogen peroxide.
- OPD o-phenylenediamine
- the HRP tag on the protein converts the OPD to a yellow colored dissolved compound.
- the solution was transferred to small-volume disposable cuvette.
- the absorbance was measured at 450 nm to quantify the amount of converted OPD, which is directly proportional to the amount of protein nonspecifically adsorbed onto the surface of the membrane. This quantity was normalized by membrane surface area (including inner and outer lumen, as well as the exposed cross-sectional faces. The results are shown in FIG. 2.
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- External Artificial Organs (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/958,937 US20160136588A1 (en) | 2014-11-19 | 2015-12-04 | Zwitterionic sulfone polymer blend and hollow-fiber membrane |
PCT/US2016/064576 WO2017096140A1 (fr) | 2015-12-04 | 2016-12-02 | Mélange de polymères sulfonés zwitterioniques et membrane à fibres creuses |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3383524A1 true EP3383524A1 (fr) | 2018-10-10 |
EP3383524A4 EP3383524A4 (fr) | 2019-07-24 |
Family
ID=58797853
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP16871564.7A Ceased EP3383524A4 (fr) | 2015-12-04 | 2016-12-02 | Mélange de polymères sulfonés zwitterioniques et membrane à fibres creuses |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP3383524A4 (fr) |
JP (1) | JP6983159B2 (fr) |
CN (1) | CN108430613B (fr) |
WO (1) | WO2017096140A1 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10851241B2 (en) | 2014-11-19 | 2020-12-01 | Cytiva Sweden Ab | Zwitterion-functionalized multicomponent copolymers and associated polymer blends and membranes |
WO2019219486A1 (fr) * | 2018-05-15 | 2019-11-21 | General Electric Company | Copolymères à composants multiples fonctionnalisés par un zwitterion et mélanges polymères et membranes associés |
EP4069405A1 (fr) | 2019-12-05 | 2022-10-12 | Solvay Specialty Polymers USA, LLC. | Procédé de préparation d'un polymère de poly(aryl éther sulfone) (paes) |
CN114941184A (zh) * | 2022-06-29 | 2022-08-26 | 山东海科创新研究院有限公司 | 纺丝液的制备方法、纺丝液及过滤膜 |
CN115779706B (zh) * | 2022-11-14 | 2024-06-21 | 西南交通大学 | 原位交联型两性离子改性聚醚砜膜及其制备方法与应用 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4758343A (en) * | 1985-09-20 | 1988-07-19 | Toray Industries, Inc. | Interfacially synthesized reverse osmosis membrane |
US4970034A (en) * | 1988-09-23 | 1990-11-13 | W. R. Grace & Co.-Conn. | Process for preparing isotropic microporous polysulfone membranes |
US5043398A (en) * | 1989-05-12 | 1991-08-27 | Hoechst Celanese Corporation | Grafting of functional compounds onto functional oxymethylene polymer backbones, with diisocyanate coupling agents, and the graft polymers thereof |
US5071448A (en) * | 1990-12-05 | 1991-12-10 | Union Carbide Industrial Gases Technology Corporation | Semipermeable membranes based on certain sulfonated substituted polysulfone polymers |
JP2003320229A (ja) * | 2002-04-30 | 2003-11-11 | Asahi Kasei Corp | 改質された中空糸膜 |
JP2005137996A (ja) * | 2003-11-05 | 2005-06-02 | Toyobo Co Ltd | 選択透過性分離膜 |
JP2008284521A (ja) * | 2007-05-21 | 2008-11-27 | Takuma Co Ltd | 中空糸状両性荷電膜及びその製造方法 |
US7985339B2 (en) * | 2008-08-25 | 2011-07-26 | General Electric Company | Polyarylether compositions bearing zwitterion functionalities |
EP2253367B1 (fr) * | 2009-05-20 | 2014-11-19 | Gambro Lundia AB | Membranes dotées de performance améliorée |
CN102029117A (zh) * | 2009-09-29 | 2011-04-27 | 中国科学院大连化学物理研究所 | 一种超滤膜表面改性方法 |
CN102294176B (zh) * | 2011-08-17 | 2013-06-26 | 浙江大学 | 一种含两性离子的高渗透性纳滤膜及其制备方法 |
JP6109492B2 (ja) * | 2012-05-22 | 2017-04-05 | 株式会社ダイセル | Nf平膜とその製造方法 |
US9440198B2 (en) * | 2014-05-16 | 2016-09-13 | General Electric Company | Zwitterion-functionalized block copolymer membranes and associated block copolymer composition |
US9085542B1 (en) * | 2014-06-12 | 2015-07-21 | General Electric Company | Method for synthesis of N-methyl piperazine diphenolamide and related composition |
CN104208766B (zh) * | 2014-08-26 | 2016-10-19 | 东华大学 | 高抗污型聚醚砜血液净化器及其制备方法 |
US20160136589A1 (en) * | 2014-11-19 | 2016-05-19 | General Electric Company | Zwitterionic sulfone polymer flat sheet membrane |
US20160136588A1 (en) * | 2014-11-19 | 2016-05-19 | General Electric Company | Zwitterionic sulfone polymer blend and hollow-fiber membrane |
US20160136587A1 (en) * | 2014-11-19 | 2016-05-19 | General Electric Company | Zwitterion-functionalized copolymer hollow-fiber membranes and associated method |
CN104804195B (zh) * | 2015-01-13 | 2018-01-23 | 西北大学 | 贻贝粘附和细胞膜抗污双仿生多臂peg及其制备方法 |
CN104607068B (zh) * | 2015-01-20 | 2017-04-12 | 苏州信望膜技术有限公司 | 一种抗生物粘附多孔分离膜、其制备方法及应用 |
-
2016
- 2016-12-02 CN CN201680070265.6A patent/CN108430613B/zh active Active
- 2016-12-02 WO PCT/US2016/064576 patent/WO2017096140A1/fr active Application Filing
- 2016-12-02 JP JP2018528026A patent/JP6983159B2/ja active Active
- 2016-12-02 EP EP16871564.7A patent/EP3383524A4/fr not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
WO2017096140A1 (fr) | 2017-06-08 |
EP3383524A4 (fr) | 2019-07-24 |
CN108430613B (zh) | 2022-02-11 |
JP2019501013A (ja) | 2019-01-17 |
JP6983159B2 (ja) | 2021-12-17 |
CN108430613A (zh) | 2018-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7681741B2 (en) | Functional polyarylethers | |
CN108430613B (zh) | 两性离子砜聚合物共混物和中空纤维膜 | |
US7695628B2 (en) | Polyarylether membranes | |
US20160136588A1 (en) | Zwitterionic sulfone polymer blend and hollow-fiber membrane | |
CA2949193C (fr) | Membranes de copolymere a blocs fonctionnalisees par un zwitterion et composition de copolymere a blocs associee | |
US20160136589A1 (en) | Zwitterionic sulfone polymer flat sheet membrane | |
US20210322933A1 (en) | Zwitterion-functionalized copolymer hollow-fiber membranes and associated method | |
JP7538116B2 (ja) | ポリアリーレンエーテル | |
CN110914336A (zh) | 磺化的聚芳基醚砜及其膜 | |
WO2008070216A1 (fr) | Membranes de fibres creuses de polyaryléthernitrile | |
JP2023126212A (ja) | ポリマードープ溶液中の共溶媒で製造する膜 | |
US7977451B2 (en) | Polyarylether membranes | |
US11407897B2 (en) | Zwitterion-functionalized multicomponent copolymers and associated polymer blends and membranes | |
US7669720B2 (en) | Functional polyarylethers | |
EP3383523A1 (fr) | Membrane en feuille plate de polymère sulfoné zwitterionique | |
US20230001362A1 (en) | Process for preparing a poly(aryl ether sulfone) (paes) polymer | |
EP3794056A1 (fr) | Copolymères à composants multiples fonctionnalisés par un zwitterion et mélanges polymères et membranes associés | |
WO2015024958A1 (fr) | Membranes de copolymère de polyarylnitrile | |
WO2023237365A1 (fr) | Membrane de filtration à caractère hydrophile amélioré | |
KR20230119135A (ko) | Bpa 및 bps가 없는 바이오-기반 설폰 공중합체 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20180704 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20190624 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: B01D 69/02 20060101ALI20190617BHEP Ipc: B01D 63/02 20060101ALI20190617BHEP Ipc: B01D 69/08 20060101ALI20190617BHEP Ipc: B01D 63/08 20060101ALI20190617BHEP Ipc: B01D 71/80 20060101AFI20190617BHEP Ipc: A61M 1/16 20060101ALI20190617BHEP Ipc: B01D 71/68 20060101ALI20190617BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20200428 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: CYTIVA SWEDEN AB |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R003 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230526 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
18R | Application refused |
Effective date: 20230520 |